Javascript must be enabled to continue!
Calciphylaxis after parathyroidectomy
View through CrossRef
AbstractA 60‐year‐old African American man with end stage renal disease on hemodialysis (HD) for the past 2.5 years developed severe hyperparathyroidism. Other past medical history included atrial fibrillation, type II diabetes mellitus, hypertension, gout, pericardial effusion needing pericardial window, deep vein thrombosis, mitral insufficiency, and cardiomyopathy with implantable cardioversion device placement. His parathyroid hormone (PTH) level peaked at 4,191 pg/mL despite being on cinacalcet, sevelamer, and paricalcitol. He underwent a subtotal parathyroidectomy in January 2015, after which his PTH levels dropped to 184 pg/mL. Approximately 4 weeks later he developed extensive, painful necrotic skin lesions in both his lower extremities and buttocks, suggestive of calciphylaxis which was confirmed by tissue biopsy. The patient was treated with elaborate wound care, wound debridements, increased dialysis dose, and IV sodium thiosulfate (STS) during hemodialysis. Besides STS, he was treated with narcotics, gabapentin, topical lidocaine on intact skin, and oral steroids for pain control. Even though his lesions improved initially, he deteriorated due to recurrent sepsis, respiratory failure, and prolonged hospitalization which culminated in stopping dialysis before he passed away. Calciphylaxis, or calcific uremic arteriolopathy, is a life‐threatening complication of end stage renal disease. Treatment of this condition is multidisciplinary which includes elaborate wound care, increasing dialysis dose, and discontinuing vitamin D supplements and calcium containing phosphate binders. Even though STS has been recommended off‐label, several studies have shown promising results with resolution of lesions. Thus, sodium thiosulfate has become the mainstay of treatment. Parathyroidectomy is a recommended modality of treatment in those with high PTH levels. Our case was unique in that calciphylaxis developed after subtotal parathyroidectomy. We believe that this is due to a decreased PTH level and decreasing bone turnover which resulted in more circulating calcium facilitating vascular and soft tissue calcification. The exact mechanism of developing calciphylaxis after parathyroidectomy is unknown. Even though parathyroidectomy is an effective treatment for calciphylaxis, clinicians should be aware that it can rarely present after parathyroidectomy.
Title: Calciphylaxis after parathyroidectomy
Description:
AbstractA 60‐year‐old African American man with end stage renal disease on hemodialysis (HD) for the past 2.
5 years developed severe hyperparathyroidism.
Other past medical history included atrial fibrillation, type II diabetes mellitus, hypertension, gout, pericardial effusion needing pericardial window, deep vein thrombosis, mitral insufficiency, and cardiomyopathy with implantable cardioversion device placement.
His parathyroid hormone (PTH) level peaked at 4,191 pg/mL despite being on cinacalcet, sevelamer, and paricalcitol.
He underwent a subtotal parathyroidectomy in January 2015, after which his PTH levels dropped to 184 pg/mL.
Approximately 4 weeks later he developed extensive, painful necrotic skin lesions in both his lower extremities and buttocks, suggestive of calciphylaxis which was confirmed by tissue biopsy.
The patient was treated with elaborate wound care, wound debridements, increased dialysis dose, and IV sodium thiosulfate (STS) during hemodialysis.
Besides STS, he was treated with narcotics, gabapentin, topical lidocaine on intact skin, and oral steroids for pain control.
Even though his lesions improved initially, he deteriorated due to recurrent sepsis, respiratory failure, and prolonged hospitalization which culminated in stopping dialysis before he passed away.
Calciphylaxis, or calcific uremic arteriolopathy, is a life‐threatening complication of end stage renal disease.
Treatment of this condition is multidisciplinary which includes elaborate wound care, increasing dialysis dose, and discontinuing vitamin D supplements and calcium containing phosphate binders.
Even though STS has been recommended off‐label, several studies have shown promising results with resolution of lesions.
Thus, sodium thiosulfate has become the mainstay of treatment.
Parathyroidectomy is a recommended modality of treatment in those with high PTH levels.
Our case was unique in that calciphylaxis developed after subtotal parathyroidectomy.
We believe that this is due to a decreased PTH level and decreasing bone turnover which resulted in more circulating calcium facilitating vascular and soft tissue calcification.
The exact mechanism of developing calciphylaxis after parathyroidectomy is unknown.
Even though parathyroidectomy is an effective treatment for calciphylaxis, clinicians should be aware that it can rarely present after parathyroidectomy.
Related Results
#744 Calciphylaxis: a qualitative study of patient experiences
#744 Calciphylaxis: a qualitative study of patient experiences
Abstract
Background and Aims
Calciphylaxis, or calcific uremic arteriolopathy (CUA), is a rare but devastating condition ...
Nonuremiccalciphylaxis - A Systematic Review
Nonuremiccalciphylaxis - A Systematic Review
Background: Calciphylaxis, also known as calcific uremic arteriolopathy, is a well-described condition in renal transplant and end-stage kidney disease (ESKD) patients; however, li...
Calciphylaxis in a patient with hypoparathyroidism and MEN-1 syndrome
Calciphylaxis in a patient with hypoparathyroidism and MEN-1 syndrome
Summary
Calciphylaxis is a rare disorder characterised by the development of painful necrotic skin lesions. Occlusion of cutaneous arterioles due to ectopic calcification leads to ...
Potential effect of sodium thiosulfate in calciphylaxis: remission of intractable pain
Potential effect of sodium thiosulfate in calciphylaxis: remission of intractable pain
Abstract
Calciphylaxis, a rare disease mainly seen in patients with chronic kidney disease, is characterised by ischaemic skin damages and excruciating pain. Calciphylaxis has poo...
Necrotic lower extremities ulcers caused by calciphylaxis in chronic renal failure patient
Necrotic lower extremities ulcers caused by calciphylaxis in chronic renal failure patient
Introduction: Lower extremity ulcers often create diagnostic challenges and influence patient morbidity and mortality. The most common causes are venous insufficiency, arterial ins...
Advantages of total parathyroidectomy in patients with secondary hyperparathyroidism induced by end stage renal disease
Advantages of total parathyroidectomy in patients with secondary hyperparathyroidism induced by end stage renal disease
IntroductionSecondary hyperparathyroidism, as a result of chronic kidney disease could be treated medically or surgically. When pharmacotherapy fails, patients undergo surgery - pa...
A Case of Calciphylaxis
A Case of Calciphylaxis
Introduction: Calciphylaxis (calcific uremic arteriolopathy), is a condition primarily observed in patients with end-stage renal disease (ESRD).
Aim: To increase clinical awareness...
A Case of Rapidly Progressive Unilateral Non-Nephrogenic Hemorrhagic Bullous Calciphylaxis Responding to Systemic Sodium Thiosulfate Therapy
A Case of Rapidly Progressive Unilateral Non-Nephrogenic Hemorrhagic Bullous Calciphylaxis Responding to Systemic Sodium Thiosulfate Therapy
Background. Calciphylaxis is a rare and life-threatening condition characterized by cutaneous necrosis resulting from vessel calcification and thrombosis. Commonly associated with ...

